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SUMMARY
This study examined the susceptibility of peritoneal macrophage (PM) from the Neotropical primates: Callithrix jacchus, Callithrix 
penicillata, Saimiri sciureus, Aotus azarae infulatus and Callimico goeldii to ex vivo Leishmania (L.) infantum chagasi-infection, 
the etiological agent of American visceral leishmaniasis (AVL), as a screening assay for evaluating the potential of these non-human 
primates as experimental models for studying AVL. The PM-susceptibility to infection was accessed by the PM-infection index (PMI) 
at 24, 72 h and by the mean of these rates (FPMI), as well as by the TNF-α, IL-12 (Capture ELISA) and Nitric oxide (NO) responses 
(Griess method). At 24h, the PMI of A. azarae infulatus (128) was higher than those of C. penicillata (83), C. goeldii (78), S. sciureus 
(77) and C. jacchus (55). At 72h, there was a significant PMI decrease in four monkeys: A. azarae infulatus (128/37), C. penicillata 
(83/38), S. sciureus (77/38) and C. jacchus (55/12), with exception of C. goeldii (78/54). The FPMI of A. azarae infulatus (82.5) and 
C. goeldii (66) were higher than C. jacchus (33.5), but not higher than those of C. penicillata (60.5) and S. sciureus (57.5). The TNF-α 
response was more regular in those four primates which decreased their PMI at 24/72 h: C. jacchus (145/122 pg/mL), C. penicillata 
(154/130 pg/mL), S. sciureus (164/104 pg/mL) and A. azarae infulatus (154/104 pg/mL), with exception of C. goeldii (38/83 pg/mL). 
The IL-12 response was mainly prominent in A. infulatus and C. goeldii which presented the highest FPMI and, the NO response 
was higher in C. goeldii, mainly at 72 h. These findings strongly suggest that these New World primates have developed a resistant 
innate immune response mechanism capable of controlling the macrophage intracellular growth of L. (L.) i. chagasi-infection, which 
do not encourage their use as animal model for studying AVL.
KEYWORDS: Peritoneal macrophage susceptibility; Neotropical primates; Leishmania (L.) infantum chagasi-infection; TNF-α; 
IL-12; Nitric oxide response.
INTRODUCTION
Leishmaniasis consists in a group of diseases caused by protozoan 
parasites belonging to the genus Leishmania Ross 1903. They are 
digenetic and heteroxenous parasites, with an obligated intracellular 
amastigote stage living and multiplying into the macrophages and, in a 
few extension, into the dendritic cells of their vertebrate hosts16,27.
Clinically, there are two different forms of leishmaniasis which exist 
depending on the Leishmania species involved and the immune-genetic 
profile of man; the cutaneous or mucocutaneous form and the visceral 
one. They comprise important anthropozoonotic diseases widely spread 
in four continents, presenting an endemic or epidemic character in many 
regions and being considered as one of the six tropical diseases of major 
interest by the World Health Organization42. 
Actually, one of the most discussed subjects at leishmaniasis 
scientific meetings is concerning the need for new experimental models 
for studying these diseases, mainly considering the possibility of using 
non-human primates due to their physiologic and phylogenetic proximity 
with humans2. Thus, the real reasons for using non-human primates 
as experimental models for studying leishmaniasis are not due to the 
ethical order but also because these animals may give rise to the clinical-
immunological features similar to those found in human diseases29.
In this way, it is interesting to record that some Neotropical primates 
have been tested before with relative success as experimental models 
for American visceral leishmaniasis (AVL), as follows: Callithrix 
jacchus, Aotus trivirgatus (Aotus infulatus) and Saimiri sciureus7,11,21. 
In a similar way, the African green monkey Cercopithecus aethiops13 
and the Presbytis entellus24,25,26 have also been used for studying the Old 
World’s visceral leishmaniasis. In this context, the successful results by 
using the Cebus apella as experimental model for studying cutaneous 
leishmaniasis due to Leishmania (V.) braziliensis, L. (L.) amazonensis 
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and L. (V.) lainsoni in the north of Brazil34,35 should also be emphasized. 
Based on these findings, it was also investigated in vivo the susceptibility 
of C. apella to experimental infection due to L. (L.) infantum chagasi, 
the etiological agent of AVL32. In contrast, however, to the experimental 
infection with the cutaneous disease agents, the C. apella showed to be 
resistant against the inoculation with either amastigote (intravenous via) 
or promastigote (intradermal via) forms of L. (L.) i. chagasi10.
Thus, regarding the above comments, we have studied the 
susceptibility of peritoneal macrophage from some species of Neotropical 
primates to L. (L.) i. chagasi-infection, aiming to evaluate the potential 
of these non-human primates as experimental model for studying AVL. 
The susceptibility of peritoneal macrophage from each monkey species 
to L. (L.) i. chagasi-infection was accessed using a screening assay which 
allowed to evaluate the peritoneal macrophage-infection index (PMI), 
as well as some pro-inflammatory cytokines (TNF-α and IL-12) and the 
nitric oxide (NO) responses. The reproducibility of this screening assay 
has been prior demonstrated through a pilot study using not only L. (L.) 
i. chagasi, but also L. (V.) braziliensis, L. (V.) guyanensis and L. (L.) 
amazonensis9, the principal etiological agents of American cutaneous 
leishmaniasis (ACL) in the north of Brazil33.
MATERIAL AND METHODS
1. Experimental animals: This study was carried out with 
Neotropical primates from the National Center of Primates (Ministry 
of Health), in Ananindeua municipality, Pará State, Brazil, where the 
peritoneal macrophage (PM) cells were collected from the five different 
species of primates: Callithrix jacchus, Callithrix penicillata, Saimiri 
sciureus, Aotus azarae infulatus and Callimico goeldii. All of them were 
young males, born and bred in captivity in the National Center of Primates 
in good environmental and dietetic conditions (Fig. 1).
This study had IBAMA license (029-2006) to collect and transport 
biological material of primates from captivity and it was approved by the 
Animal Research Ethics Committee of Evandro Chagas Institute (Health 
Ministry, Brazil), protocol number 004/2006, and the Ethics Committee 
of research programs, Medicine School of São Paulo University, São 
Paulo State, Brazil, protocol number 0255/2007.
2. Parasite: L. (L.) i. chagasi-strain (MCAO/BR/2003/M22697/Pará 
State) isolated from a dog viscera naturally infected was identified by 
monoclonal antibodies and multi-locus enzyme electrophoresis at the 
Leishmaniasis laboratory, Parasitology Department, Evandro Chagas 
Institute, Belém (PA) where the parasite was maintained in the criobank 
at -196 oC.
In order to guarantee the continued virulence of L. (L.) i. chagasi-strain, 
the stationary phase promastigotes from Difco B45 blood-agar culture 
medium39 were re-inoculated through an intra-peritoneal route in laboratory 
hamsters. Three months later, the amastigote forms from the hamsters’ 
viscera were transferred to the liquid culture medium RPMI-1640 (Sigma-
Aldrich, USA) supplemented with 10% bovine fetal serum (Cultilab); 
100 U/mL of penicillin-G; 100 µg/mL gentamicin; 2 mM L-glutamine 
and 10 mM HEPES. The parasites were then cultivated at 25 ºC and the 
stationary phase promastigote forms, established by growth-curve, showed 
to be best used after seven days of culture. The final concentration of 
stationary phase promastigotes in the inoculum was 2 x 106 /mL.
3. Isolation of peritoneal macrophage from primates: In order 
to obtain the peritoneal macrophages of the different primate species, 
the animals were anesthetized with a solution of ketamine (10 mg/kg) 
plus xylazine (1 mg/kg) (2:1 ratio) and the peritoneal cavities were 
washed with 80 mL for small size primates such as C. jacchus and C. 
penicillata, and 120 mL for middle size primates such as S. sciureus, A. 
infulatus and C. goeldii, of RPMI-1640 medium supplemented with 1.0% 
FBS, 10 mg/mL gentamicin and 100 Ul/mL penicillin. The peritoneal 
macrophage (PM) was obtained from a pool of three specimens of each 
Fig. 1 - Neotropical primate species born and bred in captivity at the National Center of Primates in Ananindeua municipality, Pará State, Brazil, that were used for studying the ex vivo peritoneal 
macrophage L. (L.) i. chagasi-infection. A- Aotus infulatus; B- Callithrix jacchus; C- Saimiri sciureus; D- Callimico goeldii and E- Callithrix penicillata.
CARNEIRO, L.A.; LAURENTI, M.D.; CAMPOS, M.B.; GOMES, C.M.C.; CORBETT, C.E.P. & SILVEIRA, F.T. - Susceptibility of peritoneal macrophage from different species of neotropical 
primates to ex vivo Leishmania (L.) infantum chagasi-infection. Rev. Inst. Med. Trop. Sao Paulo, 54(2): 95-101, 2012.
97
primate species. Following aspiration of the fluid, a suspension of cells 
was examined in a Neubauer chamber and its concentration adjusted to 
approximately 2 x 106 macrophages /mL in RPMI-1640 medium without 
serum. A volume of 50 µL (about 105 cells) of this suspension was added 
to cell-culture plates (Nunc) containing sterile cover-slips which were 
incubated at 35 0C with 5.0% CO2 for two hours to the adhesion of the 
macrophages. After this time the cover-slips were washed with RPMI-
1640 medium to remove unattached cells and an addition of 600 µL of 
RPMI-1640 was done for incubation during a further 24 hours. 
4. Macrophage-Leishmania interaction: L. (L.) i. chagasi-stationary 
phase promastigotes were washed twice by centrifugation (1,600 x g for 
10 minutes) in sterile PBS (pH 7.2), and the concentration was adjusted 
to 8 x 106 parasites/mL. The PM-infection was based on the ratio of four 
parasites per macrophage in 50 µL suspension of the cell-culture and this 
procedure was used in triplicate for each experiment. The mean of the 
triplicate values at 24 and 72 hours was the result of each experiment. 
This experiment was repeated three times for each primate species, and 
the PM-infection index (PMI) of each monkey species was based in 
the mean of these three independent experiments. Following these two 
time-points (24 and 72 hours) of cultured peritoneal macrophage L. (L.) 
i. chagasi-interaction, two more procedures were also carried out : i) the 
supernatants of these three experiments were collected in pool to evaluate 
the TNF-α, IL-12 and nitric oxide (NO) levels, thus, these results were 
expressed as unique value and not as a mean of the three experiments 
as was done for PMI; ii) the cover-slips were washed in PBS, fixed in 
absolute methyl alcohol, and stained by Giemsa to determine the PMI. 
These selected times (24 and 72 hours) for determining the PMI were used 
with the aim of observing the dynamic evolution of infection. In addition, 
an average value obtained from these two time-points of infection was 
also analyzed in attempting to represent the degree of macrophage-
infection susceptibility to each primate species; this infection-index was 
regarded as the final PMI (FPMI).
The number of infected macrophages and parasites per macrophage 
was determined in 200 cells of cover-slip from each primate species 
examined. The PMI was expressed as the percentage of infected 
macrophage multiplied by the average number of amastigotes per 
macrophage19.
5. Determination of nitric oxide (NO) response: The NO response 
was estimated by determining the nitrite concentration present in the 
supernatant of macrophage cultures infected by stationary phase culture 
promastigotes, using the Griess method15. This method consists of a 
calorimetric reaction in which the supernatant of the culture (300 µL) is 
incubated with an equal volume of recently prepared Greiss reagent (1.0% 
sulfanilamide, 0.1% naphazoline hydrochloride, and 2.5% orthophosforic 
acid) for 10 minutes at room temperature. The absorbance was determined 
in a Zeiss spectrophotometer, with an optic density of 540 nm against 
to a white formed by culture medium (RPMI-1640) and Griess reagent 
in equal proportions. The results were expressed as mM of NO based on 
a standard curve formed with known concentrations of sodium nitrites 
(NaNO2) dissolved in culture medium. In all assays, the control was the 
supernatant from an uninfected macrophage culture. 
6. Determination of TNF-α and IL-12 response: An ELISA anti-
monkey assay was used for evaluating the TNF-α and IL-12 response 
in the supernatants from the peritoneal macrophage cultures infected 
with L. (L.) i. chagasi, using available commercial kits (Biosource 
Laboratory®). All assays were performed in accordance with the 
manufacturer instructions. The assays sensitivities were < 2 pg/mL for 
TNF-α and < 4 pg/mL for IL-12. 
7. Statistics: The statistically significant differences of the infection 
rates (PMI and FPMI), cytokines (TNF-α and IL-12) and NO levels 
amongst the different species of primates were obtained using the Bio-
Estat 4.0 software4. The binomial and c2 tests for independent variables 
were used to compare these differences with p < 0.05 considered to be 
significant.
RESULTS
1. PMI and FPMI of neotropical monkeys by L. (L.) i. chagasi: At 24 
hours of infection, it was observed that PMI of A. azarae infulatus (128) 
was higher (p < 0.05) than those other primates: C. penicillata (83), C. 
goeldii (78), S. sciureus (77) and C. jacchus (55), amongst which there 
were no differences (p > 0.05) (Fig. 2).
At 72 hours of infection, there was a significant (p < 0.05) decrease 
in the PMI of four primates, as follows: A. azarae infulatus 128/37, C. 
penicillata 83/38, S. sciureus 77/38 and C. jacchus 55/12, with exception 
of C. goeldii 78/54 (p > 0.05) which was also the only primate with PMI 
(54) higher (p < 0.05) than that of C. jacchus (12). Thus, it should be 
emphasized that the PMI(s) of C. jacchus, at 24 (55) and 72 (12) hours 
of infection were the lowest amongst all primates examined (Fig. 2).
With regards to the FPMI, it was noted that A. azarae infulatus 
(82.5) and C. goeldii (66) showed the highest rates of infection, although 
they were only higher (p < 0.05) than that of C. jacchus (33.5), but not 
(p > 0.05) than C. penicillata (60.5) and S. sciureus (57.5) (Fig. 2). 
2. TNF-α, IL-12 and NO responses of ex vivo peritoneal 
macrophage-infection 
2.1. TNF-α response: At 24 hours of infection, there were not found 
differences (p > 0.05) of TNF-α levels in the supernatants of infected PM-
cultures of the primates S. sciureus (164 pg/µL), C. jacchus (145 pg/mL), 
Fig. 2 - Average and standard deviation of the infection index of peritoneal macrophage of 
Neotropical primates infected with promastigotes of L. (L.) i. chagasi, where: (a) Infection 
Index of A. infulatus > C. penicillata, S. sciureus, C. goeldii and C.jacchus at 24 hours; (b) 
Infection index of A. infulatus, C. penicillata, S. sciureus, and C.jacchus at 24 hours > 72 
hours; (c) Infection index of C. goeldii > C. jacchus at 72 hours; (d) Final infection index of 
A. infulatus and C. goeldii > C. jacchus (p < 0.05).
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C. penicillata (154 pg/mL) and A. azarae infulatus (154 pg/mL), although 
these levels were higher (p < 0.05) than C. goeldii (39 pg/mL) (Fig. 3). 
At 72 hours of infection, there were two notable findings; first, it 
was observed that the TNF-α levels found in four primates have shown 
similar profiles (p > 0.05) to those at 24 hours of infection: S. sciureus 
(104 pg/mL), C. jacchus (122 pg/mL), C. penicillata (130 pg/mL) and 
A. azarae infulatus (153 pg/mL); second, it was noted that although the 
TNF-α level of C. goeldii (83 pg/mL) had increased (p < 0.05) concerning 
the 24 hours of infection (39 pg/mL), this increase was not able to avoid 
the condition of the lowest TNF-α-produced primate species. In addition, 
it was also noted that the TNF-α levels found in the supernatants of non-
infected PM-cultures (controls) had similar profiles to those of infected 
PM-cultures (24 and 72 hours), such as: S. sciureus 90 pg/mL, C. jacchus 
90 pg/mL, C. penicillata 105 pg/mL and, A. azarae infulatus 124 pg/mL. 
Thus, they were also higher (p < 0.05) than C. goeldii (29 pg/mL), which 
were demonstrated in the infected PM-cultures (39 and 83 pg/mL) and in 
the PM controls (29 pg/mL), the TNF-α levels of C. goeldii were lower 
(p < 0.05) than those other primates (Fig. 3).
2.2. IL-12 response: At 24 hours of infection, there were not found 
differences (p > 0.05) of IL-12 levels in the supernatants of infected PM-
cultures of the monkeys S. sciureus (153 pg/mL) and C. jacchus (117 pg/
mL), just the two primate species with the lowest FPMI (57.5 and 33.5). 
However, it was also observed that the IL-12 levels of A. azarae infulatus 
(419 pg/mL) and C. goeldii (456 pg/mL), the two primates with the highest 
FPMI (82.5 and 66), were higher (p < 0.05) than those of C. jacchus (117 
pg/mL) and S. sciureus (153 pg/mL), but not than the C. penicillata (283 
pg/mL) which occupied an intermediary (60.5) FPMI level (Fig. 4).
Following 72 hours of infection, it was detected a significant 
increase (p < 0.05) of IL-12 levels in the supernatants of infected 
PM-cultures of A. azarae infulatus (419/24h→690/72h pg/mL) and C. 
goeldii (456/24h→666/72h pg/mL), but not (p > 0.05) in C. penicillata 
(283/24h→333/72h pg/mL). In contrast, there was a relative decrease 
(p > 0.05) of IL-12 levels in the supernatants of infected PM-cultures of 
C. jacchus (117/24h→74/72h pg/mL) and S. sciureus (153/24h→98/72h 
pg/mL) (Fig. 4). Thus, the impression regarding the IL-12 response at 72 
hours of experiment was similar to what happened at 24 hours.
2.3. Nitric oxide (NO) response: At 24 hours of infection, it was 
demonstrated that the NO levels detected in the supernatants of infected 
PM-cultures of C. jacchus (3.2 µM) were higher (p < 0.05) than those 
other primate species; C. penicillata (0.3 µM), A. azarae infulatus 
(0.7 µM), S. sciureus (0.9 µM) and C. goeldii (0.5 µM), amongst which 
there were not found (p > 0.05) differences (Fig. 5).
At 72 hours of infection, it was noted an important (p < 0.05) 
NO response in the supernatants of infected PM-cultures of those 
primates which have showed low NO levels at 24 hours of infection, 
as follows: C. penicillata (0.3/24h→1.25/72h µM), A. azarae infulatus 
(0.7/24h→1.3/72h µM), S. sciureus (0.9/24h→3.3/72h µM) and, 
surprising, C. goeldii (0.5/24h→5.5/72h µM). In contrast, there 
was a relative (p > 0.05) decrease in the NO response of C. jacchus 
(3.2/24h→2.3/72h µM), which was only lower (p < 0.05) than the C. 
goeldii (5.5 µM) (Fig. 5).
DISCUSSION
Firstly, it should be emphasized that the most interesting feature of 
Fig. 3 - Concentration of TNF-α (pg/mL) in the supernatants of peritoneal macrophage cultures 
of Neotropical primates infected with promastigotes of L. (L.) i. chagasi, where: (a) C. goeldii 
< S. sciureus, A. infulatus, C. penicillata and C. jacchus at 24 hours; (b) C. goeldii at 24 hours 
< 72 hours; (c).Non infected cultures of C. goeldii < S. sciureus, A. infulatus, C. penicillata 
and C. jacchus (p < 0.05).
Fig. 4 - Concentration of IL-12 (pg/mL) in the supernatants of peritoneal macrophage cultures 
of Neotropical primates infected with promastigotes of L. (L.) i. chagasi, where: (a) C. goeldii 
and A. infulatus > S. sciureus and C. jacchus at 24 hours; (b) C. goeldii and A. infulatus at 
24 hours < 72 hours (p < 0.05).
Fig. 5 - Concentration of nitric oxide (NO) (mM) in the supernatants of peritoneal macrophage 
cultures of Neotropical primates infected with promastigotes of L. (L.) i. chagasi, where: (a) C. 
jacchus > C. penicillata, A. infulatus, S. sciureus and C. goeldii; (b) A. infulatus, C. penicillata, 
S. sciureus and C. goeldii at 24 hours < at 72 hours; (c) C. goeldii > C. jacchus (p < 0.05).
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this work was the use of the peritoneal macrophage from five different 
species of Neotropical primates: C. jacchus, C. penicillata, S. sciureus, 
C. goeldii and A. azarae infulatus for studying its susceptibility to ex 
vivo L. (L.) i. chagasi-infection, the etiological agent of AVL. Thus, it 
was tried to identify which monkey species would have the potential of 
susceptibility to in vivo L. (L.) i. chagasi infection, aiming to establish 
an experimental model which might be useful for reproducing the 
parasitological, clinical and immunological features found in human 
AVL. Besides, it was also desired to demonstrate in the supernatants of 
L. (L.) i. chagasi-infected peritoneal macrophage cultures the production 
of some pro-inflammatory cytokines, such as TNF-α and IL-12, as well as 
the NO, which are strongly associated to the development of macrophage 
resistance against Leishmania-infection5,22,31.
In this way, two rates were used for evaluating the susceptibility 
of peritoneal macrophage from Neotropical primates: i) the peritoneal 
macrophage-infection index (PMI) at intervals of 24 and 72 hours of 
infection and, ii) the final peritoneal macrophage-infection index (FPMI) 
accessed by the average of these two time-points rates, which aimed to 
express the potential susceptibility of each primate species to ex vivo 
L. (L.) i. chagasi-infection. Considering that TNF-α, IL-12 and NO 
assays were also performed at the same time-points (24 and 72 hours) 
of the peritoneal macrophage-infection index (PMI) the susceptibility of 
peritoneal macrophage of these primates to L. (L.) i. chagasi-infection 
was based in these two immune-biological parameters of infection, which 
have been regarded of pivotal importance to analyze the macrophage 
resistance against Leishmania-infection3,20.
Taking into account these criteria, it was initially considered that 
two primate species had some potential susceptibility to ex vivo L. (L.) 
i. chagasi-infection: A. azarae infulatus and C. goeldii, with FPMI of 
82.5 and 66, respectively. However, it should not be omitted that these 
two rates were not different (p > 0.05) from those of C. penicillata (60.5) 
and S. sciureus (57.5) monkeys and were only different (p < 0.05) from 
C. jacchus (33.5), which presented the lowest FPMI. Thus, if the PM-
susceptibility to infection is based only in the FPMI, the first impression 
would be that these four primate species with the highest FPMI rates, 
A. azarae infulatus (82.5), C. goeldii (66), C. penicillata (60.5) and S. 
sciureus (57.5), would have equivalent degrees of PM-susceptibility to L. 
(L.) i. chagasi-infection and would all be indicated for in vivo studying 
of AVL. Thus, it seems reasonable to assume that neither PMI nor FPMI 
showed significant differences that should indicate any primate species 
as candidate for in vivo studying AVL. In contrast, another conclusion 
regarding C. jacchus that should be indicated as an experimental model 
for studying the cellular immune mechanisms related to resistance 
against infection.
Another point of consideration was the originality of this approach, 
which used the peritoneal macrophage from five different Neotropical 
primates to study its susceptibility to L. (L.) i. chagasi-infection; indeed, 
the findings obtained in this work were difficult to be compared with 
others, once the majority of studies in this area has been made with 
BALB/c mice peritoneal macrophage, as the target cell to be infected8,14. 
Besides some studies using dermotropic Leishmania sp., PINELLI 
et al.30 had used a cellular lineage of canine macrophage (030-D) to 
evaluate the role of NO in the control of L. (L.) infantum-infection, the 
etiological agent of visceral leishmaniasis in some European countries 
of Mediterranean Basin and a leishmanial parasite closely related to L. 
(L.) i. chagasi; the findings of these authors have confirmed that NO 
production in the cultured macrophage cells exerts a crucial decrease 
on the intracellular growth of the parasite. In another study using 
canine peritoneal macrophage, MADEIRA et al.18 have demonstrated 
the infection of the same cellular lineage by L. (L.) i. chagasi, L. (L.) 
amazonensis and L. (V.) braziliensis during consecutive six days in RPMI 
culture, encouraging this approach to be used in screening assays for 
testing the sensitivity of these parasites against new drugs for treatment 
of canine leishmaniasis. Thus, the present work represents an original 
approach providing pioneer results on the interaction of L. (L.) i. chagasi 
with peritoneal macrophage from New World primates, which may also 
be used as an approach assay for studying the immune mechanisms 
involved with Leishmania-infection. 
With regard to TNF-α, IL-12 and NO macrophage responses, 
which play in a synergy manner a resistant innate immune response 
against Leishmania-infection41, it was observed that each one of these 
immune mechanisms have been recorded in the L. (L.) i. chagasi-
infected peritoneal macrophage from all Neotropical primates examined. 
Furthermore, it should also be emphasized the pivotal role of TNF-α in 
developing the immune macrophage resistance against infection, in view 
of its regular response in four of five monkeys between 24 to 72 hours of 
experiment: C. jacchus 145/122 pg/mL, C. penicillata 154/130 pg/mL, 
S. sciureus 164/104 pg/mL and A. azarae infulatus 154/104 pg/mL, with 
exception C. goeldii (38/83 pg/mL). Considering that TNF-α has been 
regarded as a pro-inflammatory cytokine with a crucial role in mediating 
host protection against Leishmania-infection17,37,38, these findings allowed 
speculation that TNF-α response was responsible for the significant 
(p < 0.05) PMI decrease found in these four primates (C. jacchus 55/12, 
C. penicillata 83/38, S. sciureus 77/38 and A. azarae infulatus 128/37 
pg/mL), with exception C. goeldii 78/54 pg/mL (p > 0.05). 
On the other hand, IL-12 response was also a prominent cytokine in 
this study, mainly regarding those two primates with the highest FPMI, 
A. azarae infulatus and C. goeldii, which showed at 72 hours of infection, 
the higher levels of IL-12 than those of C. jacchus, C. penicillata and S. 
sciureus, suggesting a delayed IL-12 response in attempting to increase 
the macrophage resistance against the parasite replication. This appears 
in according with the major role for IL-12 cytokine that bridges the 
innate and acquired immune response, leading T-cell response toward 
to Th1 cytokine profile1,23.
The NO-mediated leishmanicidal activity, derived from the inducible 
nitric oxide synthesis (iNOS), has widely been recognized either in 
experimental infection or in human disease as a major cellular defensive 
mechanism against the amastigote-intracellular growth of Leishmania 
sp.12,28,36. However, for this activity the TNF-α and IL-12 production is 
necessary, which will then provide the macrophage activation and the 
subsequent NO response6,40. In this way, two major findings related to NO 
response should be taken into consideration: first, it was demonstrated, at 
24 hours of infection, a very important NO response in the PM-cultures 
of C. jacchus that monkey species with the lowest FPMI and with an 
expressive TNF-α response; second, it was observed, at 72 hours of 
infection, an expressive recovery of NO response in those primates which 
have showed low NO levels at 24 hours of infection, mainly in C. goeldii 
which has also showed significant IL-12 response, thus, suggesting 
in both situations the role of either TNF-α or IL-12 cytokines in the 
developing of macrophage resistance.
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Taking all these findings together, as well as prior results on the in 
vivo susceptibility of C. apella monkey to experimental infection by L. 
(L.) i. chagasi10, there appears to be enough evidence to suggest that these 
New World primates have developed resistant innate immune response 
mechanisms capable of controlling the parasite intracellular growth 
within macrophages, contradicting their use as experimental model of 
susceptibility to the infection by L. (L.) i. chagasi.
RESUMO
Susceptibilidade do macrófago peritoneal de diferentes  
espécies de primatas neotropicais para a infecção ex vivo  
por Leishmania (L.) infantum chagasi
Este estudo examinou a susceptibilidade do macrófago peritoneal 
(PM) dos primatas neotropicais: Callithrix jacchus, Callithrix penicillata, 
Saimiri sciureus, Aotus azarae infulatus e Callimico goeldii para 
a infecção ex vivo por Leishmania (L.) infantum chagasi, o agente 
etiológico da leishmaniose visceral americana (LVA), como método 
de triagem para avaliar o potencial desses primatas como modelo de 
estudo da LVA. A susceptibilidade do PM para a infecção foi investigada 
através do índice de infecção do PM (PMI) a intervalos de 24, 72 horas 
e, ainda, pela média dessas taxas (FPMI), assim como, pelas respostas 
do TNF-α, IL-2 (ELISA de captura) e óxido nítrico (NO) (método de 
Griess). Às 24hs da infecção experimental, o PMI do primata A. azarae 
infulatus (128) foi maior que aqueles de C. penicillata (83), C. goeldii 
(78), S. sciureus (77) e C. jacchus (55). Às 72hs, houve uma redução 
significativa do PMI de quatro primatas: A. azarae infulatus (128/37), 
C. penicillata (83/38), S. sciureus (77/38) e C. jacchus (55/12), com 
exceção de C. goeldii (78/54). O FPMI dos primatas A. azarae infulatus 
(82.5) e C. goeldii (66) foi maior que do primata C. jacchus (33.5), 
porém, não foi maior que dos primatas C. penicillata (60.5) e S. sciureus 
(57.5). A resposta do TNF-α foi mais regular nos quatro primatas que 
reduziram o PMI no intervalo de 24-72hs: C. jacchus (145/122 pg/µL), 
C. penicillata (154/130 pg/µL), S. sciureus (164/104 pg/µL) e A. azarae 
infulatus (154/104 pg/µL), com exceção de C. goeldii (38/83 pg/µL). 
A resposta de IL-12 foi, principalmente, marcante nos primatas A. 
azarae infulatus e C. goeldii, os quais apresentaram as maiores taxas do 
FPMI, e a resposta do NO foi maior no primata C. goeldii, em especial 
no intervalo de 72hs. Estes achados sugerem, fortemente, que estes 
primatas neotropicais parecem ter desenvolvido mecanismos resistentes 
de resposta imune inata capaz de controlar o crescimento intracelular da 
infecção por L. (L.) i. chagasi no macrófago, o que não encoraja o uso 
destes primatas como modelo de estudo da LVA. 
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